In the current study we aimed to clarify the potential of EpCAM and villin as in vivo
biomarkers for both Barrett esophagus (BE)-associated neoplasia and BE versus cardiac …

Barrett's esophagus (BE) is a metaplastic change of the squamous esophageal epithelium to
columnar gastric or intestinal‐like epithelium. BE is associated with long‐standing …

Aims: To characterise a specific and sensitive marker of Barrett's metaplasia (BM). Methods:
Cases of normal oesophageal squamous mucosa (11 fresh endoscopic biopsies and 10 …

Barrett's esophagus (BE) is a premalignant condition associated with the development of
esophageal adenocarcinoma (EAC). Despite the low risk of progression to EAC, evidence …

Background: The epithelial cell adhesion molecule (Ep‐CAM) is widely associated with
human carcinomas. However, the expression and distribution of Ep‐CAM in gastric …

PCNA and esophagin have been implicated in the multistep process of carcinogenesis, but
simultaneous characterization of these proteins in the early stages of esophageal neoplastic …

In esophageal neoplasms, the histopathologic differentiation between Barrett's esophagus
with or without intraepithelial neoplasia and adenocarcinoma is often challenging …

It is important to distinguish Barrett's esophagus (BE) from intestinal metaplasia related to
carditis because these conditions have a different natural history, risk of malignancy, and …

Objective. Barrett's esophagus (BE) is a premalignant condition of the distal esophagus. For
diagnostic purposes it is important to find biomarkers that can specifically identify BE, for …

Background Carcinomas of the Vaterian system are rare and presumably arise from pre-
existing adenomas. According to the cancer stem cell (CSC) hypothesis, only a small subset …